These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1419811)

  • 21. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.
    Chen AY; Guan W; Lou S; Liu Z; Kleiboeker S; Qiu J
    J Virol; 2010 Dec; 84(23):12385-96. PubMed ID: 20861249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parvovirus B19 integration into human CD36+ erythroid progenitor cells.
    Janovitz T; Wong S; Young NS; Oliveira T; Falck-Pedersen E
    Virology; 2017 Nov; 511():40-48. PubMed ID: 28806616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro.
    Lindton B; Tolfvenstam T; Norbeck O; Markling L; Ringdén O; Westgren M; Broliden K
    Fetal Diagn Ther; 2001; 16(1):26-31. PubMed ID: 11125248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Erythrocyte P antigen: cellular receptor for B19 parvovirus.
    Brown KE; Anderson SM; Young NS
    Science; 1993 Oct; 262(5130):114-7. PubMed ID: 8211117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired genome encapsidation restricts the in vitro propagation of human parvovirus B19.
    Wolfisberg R; Ruprecht N; Kempf C; Ros C
    J Virol Methods; 2013 Oct; 193(1):215-25. PubMed ID: 23764418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry.
    Weigel-Kelley KA; Yoder MC; Srivastava A
    Blood; 2003 Dec; 102(12):3927-33. PubMed ID: 12907437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An in situ hybridization technique for the study of B19 human parvovirus replication in bone marrow cell cultures.
    Vassias I; Perol S; Coulombel L; Thebault MC; Lagrange PH; Morinet F
    J Virol Methods; 1993 Oct; 44(2-3):329-38. PubMed ID: 8263124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parvovirus B19 and the pathogenesis of anaemia.
    Chisaka H; Morita E; Yaegashi N; Sugamura K
    Rev Med Virol; 2003; 13(6):347-59. PubMed ID: 14625883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential transcription, without replication, of non-structural and structural genes of human parvovirus B19 in the UT7/EPO cell as demonstrated by in situ hybridization.
    Leruez M; Pallier C; Vassias I; Elouet JF; Romeo P; Morinet F
    J Gen Virol; 1994 Jun; 75 ( Pt 6)():1475-8. PubMed ID: 8207413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex.
    Ganaie SS; Zou W; Xu P; Deng X; Kleiboeker S; Qiu J
    PLoS Pathog; 2017 May; 13(5):e1006370. PubMed ID: 28459842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted expression from parvovirus B19p6 promoter in primary human hematopoietic progenitor cells.
    Kurpad C; Mukherjee P; Wang XS; Ponnazhagan S; Li L; Yoder MC; Srivastava A
    J Hematother Stem Cell Res; 1999 Dec; 8(6):585-92. PubMed ID: 10645765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells.
    Chen AY; Zhang EY; Guan W; Cheng F; Kleiboeker S; Yankee TM; Qiu J
    Blood; 2010 Feb; 115(5):1070-80. PubMed ID: 19861680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells.
    Weigel-Kelley KA; Yoder MC; Srivastava A
    J Virol; 2001 May; 75(9):4110-6. PubMed ID: 11287560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxyurea inhibits parvovirus B19 replication in erythroid progenitor cells.
    Bonvicini F; Bua G; Conti I; Manaresi E; Gallinella G
    Biochem Pharmacol; 2017 Jul; 136():32-39. PubMed ID: 28377277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral activity of brincidofovir on parvovirus B19.
    Bua G; Conti I; Manaresi E; Sethna P; Foster S; Bonvicini F; Gallinella G
    Antiviral Res; 2019 Feb; 162():22-29. PubMed ID: 30529090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible involvement of miRNAs in tropism of Parvovirus B19.
    Anbarlou A; AkhavanRahnama M; Atashi A; Soleimani M; Arefian E; Gallinella G
    Mol Biol Rep; 2016 Mar; 43(3):175-81. PubMed ID: 26878856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heat stability of parvovirus B19: kinetics of inactivation.
    Schwarz TF; Serke S; Von Brunn A; Hottenträger B; Huhn D; Deinhardt F; Roggendorf M
    Zentralbl Bakteriol; 1992 Jul; 277(2):219-23. PubMed ID: 1520981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human parvovirus B19 induces cell cycle arrest at G(2) phase with accumulation of mitotic cyclins.
    Morita E; Tada K; Chisaka H; Asao H; Sato H; Yaegashi N; Sugamura K
    J Virol; 2001 Aug; 75(16):7555-63. PubMed ID: 11462027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human parvovirus B19 vectors.
    Weigel-Kelley KA; Srivastava A
    Pathol Biol (Paris); 2002 Jun; 50(5):295-306. PubMed ID: 12116848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of neutralizing anti-B19 parvovirus human monoclonal antibodies from patients infected with human immunodeficiency virus.
    Arakelov S; Gorny MK; Williams C; Riggin CH; Brady F; Collett MS; Zolla-Pazner S
    J Infect Dis; 1993 Sep; 168(3):580-5. PubMed ID: 8354899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.